Study guide

3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing

Key Takeaways Explain This Topic AI

In primary endocrine disease the target hormone and its pituitary trophic hormone move in opposite directions, while secondary (pituitary) disease moves both in the same direction.

Suspected hormone deficiency is confirmed with a stimulation test and suspected hormone excess with a suppression test, such as dexamethasone suppression for Cushing syndrome.

High-dose biotin falsely lowers sandwich immunoassays such as TSH and falsely raises competitive assays such as free T4, mimicking hyperthyroidism.

Plasma free metanephrines or 24-hour urine fractionated metanephrines are the first-line screening tests for pheochromocytoma; urine VMA and HVA support neuroblastoma.

Immunoassays measure the beta subunit of hCG because its alpha subunit is identical to that of LH, FSH, and TSH.

Last updated: October 2026

Endocrinology: Hormone Physiology and Endocrine Function Testing

Endocrine testing is a small but reliable slice of the Clinical Chemistry board subject, which RA 5527 weights at 20% of the MTLE. Questions rarely ask for obscure hormones. They test whether you can read a feedback pattern (which gland failed first), pick the right screening or confirmatory test, and recognize the immunoassay artifacts that send a clinician the wrong way. This section covers hormone classes and assay pitfalls, the thyroid and adrenal cortex axes, the adrenal medulla, mineralocorticoids, parathyroid and posterior pituitary hormones, growth hormone and prolactin, and reproductive hormones including hCG.

  • 1. Hormone Classes, Feedback Logic, and Immunoassay Pitfalls
  • Three Chemical Classes

Class Examples Solubility and Transport Receptor Site Practical Consequence

Peptide / protein / glycoprotein Insulin, ACTH, TSH, LH, FSH, hCG, PTH, GH, prolactin, ADH Water-soluble; travel mostly free Cell-membrane receptor with second messenger (cAMP, IP3) Short half-lives (minutes); pulsatile hormones such as GH and ACTH need timed or stimulated samples

Steroid Cortisol, aldosterone, estradiol, progesterone, testosterone Lipid-soluble; bound to carrier proteins (CBG, SHBG, albumin) Intracellular (cytoplasmic or nuclear) receptor Total levels change when binding proteins change (pregnancy, estrogen therapy)

Amine Catecholamines (epinephrine, norepinephrine, dopamine); thyroid hormones (T4, T3) Catecholamines are water-soluble; thyroid hormones are carrier-bound like steroids Membrane receptors (catecholamines); nuclear receptors (thyroid hormones) Catecholamines are labile and need acid-preserved urine or chilled plasma

Reading a Feedback Loop

Primary disease starts in the target gland. The target hormone and the pituitary trophic hormone move in opposite directions (low cortisol with high ACTH in Addison disease).

Secondary disease starts in the pituitary, and tertiary disease in the hypothalamus. Both hormones move in the same direction (low cortisol with low ACTH).

Rule for dynamic tests: suspect deficiency, stimulate (cosyntropin for adrenal insufficiency, insulin tolerance or arginine for GH deficiency); suspect excess, suppress (dexamethasone for Cushing syndrome, glucose load for acromegaly).

Immunoassay Pitfalls the Board Likes

High-dose hook (prozone) effect: In one-step sandwich immunoassays, an extremely high antigen concentration saturates both capture and detection antibodies, so the signal is falsely low. Classic examples are very high hCG (molar pregnancy, choriocarcinoma) and giant prolactinomas. Re-assay after serial dilution.

Heterophile antibodies and HAMA: Human antibodies against animal immunoglobulins bridge the capture and detection antibodies and create a false-positive signal. Suspect it when a result does not fit the clinical picture; blocking reagents or a different platform resolve it.

Biotin interference: High-dose biotin supplements interfere with streptavidin-biotin assays. Sandwich assays (TSH, troponin, hCG) read falsely low , and competitive assays (free T4, free T3) read falsely high , which can mimic hyperthyroidism.

Macroprolactin: Prolactin bound to IgG is biologically inactive but reacts in most assays. Polyethylene glycol (PEG) precipitation separates it from monomeric prolactin.

  • 2. Thyroid and Adrenal Cortex Axes
  • The Hypothalamic-Pituitary-Thyroid (HPT) Axis HYPOTHALAMUS
  • |
  • Thyrotropin-Releasing Hormone (TRH)
  • |
  • v
  • ANTERIOR PITUITARY
  • |
  • Thyroid-Stimulating Hormone (TSH)
  • |
  • v
  • THYROID GLAND
  • |
  • +----------+----------+
  • | |
  • Thyroxine (T4) Triiodothyronine (T3)
  • | |
  • +----------+----------+
  • |
  • v
  • Negative Feedback on Pituitary & Hypothalamus

Thyroid hormones are synthesized from tyrosine residues on thyroglobulin within thyroid follicles, iodinated to form monoiodotyrosine (MIT) and diiodotyrosine (DIT), and coupled into thyroxine ( T 4 T_4 T 4 ​ , 90%) and triiodothyronine ( T 3 T_3 T 3 ​ , 10%) . In circulation, >99.9% of T 4 T_4 T 4 ​ and >99.7% of T 3 T_3 T 3 ​ are bound to plasma carrier proteins ( Thyroid-Binding Globulin [TBG] , transthyretin, and albumin). Only the unbound free fractions (Free T 4 T_4 T 4 ​ , Free T 3 T_3 T 3 ​ ) enter cells to exert metabolic actions and provide negative feedback inhibition on pituitary TSH secretion.

Diagnostic Interpretation of Thyroid Profiles

Clinical Condition TSH Free T 4 T_4 T 4 ​ Free T 3 T_3 T 3 ​ Clinical Features / Etiologies

Primary Hypothyroidism Markedly High ( > 10 mIU/L >10\text{ mIU/L} > 10 mIU/L ) Low Low / Normal Hashimoto thyroiditis, iodine deficiency, post-thyroid ablation; fatigue, cold intolerance, weight gain, myxedema

Subclinical Hypothyroidism Mildly High ( 4.5 − 10 mIU/L 4.5-10\text{ mIU/L} 4.5 − 10 mIU/L ) Normal Normal Early thyroid gland failure; normal target hormone maintained by elevated trophic drive

Primary Hyperthyroidism Suppressed / Undetectable ( < 0.01 mIU/L <0.01\text{ mIU/L} < 0.01 mIU/L ) High High Graves disease (TSH-receptor stimulating antibodies), toxic multinodular goiter; heat intolerance, palpitations, weight loss, exophthalmos

Secondary (Pituitary) Hypothyroidism Low or Inappropriately Normal Low Low Pituitary adenoma, Sheehan syndrome (panhypopituitarism); lack of trophic stimulation

Secondary Hyperthyroidism High High High Rare TSH-secreting pituitary adenoma

Elevated TBG (Euthyroid State) Normal Normal Normal Pregnancy, oral contraceptives, high estrogen; Total T 4 T_4 T 4 ​ is elevated , but Free T 4 T_4 T 4 ​ and TSH remain strictly normal

The Hypothalamic-Pituitary-Adrenal (HPA) Axis and Cortisol Dynamics

Cortisol is a glucocorticoid synthesized in the zona fasciculata of the adrenal cortex under the control of hypothalamic Corticotropin-Releasing Hormone (CRH) and anterior pituitary Adrenocorticotropic Hormone (ACTH) .

Circadian / Diurnal Rhythm: Cortisol exhibits a pronounced diurnal secretion pattern in healthy individuals. Peak circulating concentrations occur immediately after waking in the early morning ( 6:00 AM – 8:00 AM , reference 10 − 20 μ g/dL 10-20\text{ }\mu\text{g/dL} 10 − 20 μ g/dL ); concentrations fall steadily throughout the day, reaching an evening nadir at midnight ( midnight trough , reference < 5 μ g/dL <5\text{ }\mu\text{g/dL} < 5 μ g/dL , <50% of morning peak). Loss of this normal diurnal variation is an early biochemical hallmark of Cushing syndrome .

Cushing Syndrome (Hypercortisolism):

First-Line Screening Tests: (1) 24-hour urinary free cortisol (UFC), (2) late-night salivary cortisol (demonstrating loss of midnight nadir), or (3) low-dose ( 1 mg 1\text{ mg} 1 mg ) overnight dexamethasone suppression test (DST) . Dexamethasone is a potent synthetic glucocorticoid that normally suppresses ACTH and early morning cortisol to < 1.8 μ g/dL <1.8\text{ }\mu\text{g/dL} < 1.8 μ g/dL . Failure to suppress confirms autonomous hypercortisolism.

Etiological Differentiation: Plasma ACTH is measured:

ACTH-Dependent Cushing: High or normal ACTH. Caused by a pituitary ACTH-secreting microadenoma ( Cushing Disease , ≈ 70 % \approx 70\% ≈ 70% ) or ectopic ACTH secretion (small cell lung carcinoma).

ACTH-Independent Cushing: Suppressed/undetectable ACTH. Caused by autonomous adrenal adenoma, adrenal carcinoma, or exogenous corticosteroid intake.

Addison Disease (Primary Adrenal Insufficiency): Autoimmune destruction of all three zones of the adrenal cortex, causing deficiency of cortisol, aldosterone, and adrenal androgens.

Laboratory Profile: Inappropriately low baseline morning cortisol with markedly elevated ACTH (elevated ACTH processing generates melanocyte-stimulating hormone, producing cutaneous and mucosal hyperpigmentation). Electrolytes show hyponatremia, hyperkalemia, and mild non-anion gap metabolic acidosis due to lack of aldosterone.

Confirmatory Test: Cosyntropin (synthetic ACTH) stimulation test . Baseline cortisol is measured, 250 μ g 250\text{ }\mu\text{g} 250 μ g of cosyntropin is administered intramuscularly or intravenously, and cortisol is measured at 30 and 60 minutes. Healthy adrenals respond with a brisk rise to > 18 − 20 μ g/dL >18-20\text{ }\mu\text{g/dL} > 18 − 20 μ g/dL ; in primary Addison disease, the atrophic adrenals show no response.

3. Adrenal Medulla: Catecholamines and Their Metabolites

Chromaffin cells of the adrenal medulla convert tyrosine to dopamine, norepinephrine, and epinephrine. Catecholamines are metabolized by catechol-O-methyltransferase (COMT) to metanephrine and normetanephrine , and by monoamine oxidase (MAO) and COMT to the end product vanillylmandelic acid (VMA) . Dopamine is metabolized to homovanillic acid (HVA) .

Pheochromocytoma and paraganglioma: Tumors cause paroxysmal hypertension, headache, sweating, and palpitations. Plasma free metanephrines or 24-hour urine fractionated metanephrines are the first-line screening tests because tumors metabolize catecholamines to metanephrines continuously, even between episodes. Urine VMA is less sensitive.

Neuroblastoma: A childhood tumor of neural crest origin. Urine VMA and HVA , often measured on a random specimen and reported per gram of creatinine, are elevated in most cases.

Specimen handling: Collect 24-hour urine with an acid preservative (commonly hydrochloric acid) to keep catecholamines stable. Strenuous exercise, stress, caffeine, and several drugs (such as tricyclic antidepressants and MAO inhibitors) raise results. Older colorimetric VMA methods also reacted with dietary vanilla, banana, and coffee compounds, which is why older texts list diet restrictions.

  • 4. Mineralocorticoids, Parathyroid Hormone, and Antidiuretic Hormone
  • Aldosterone and the Renin-Angiotensin System

Aldosterone from the zona glomerulosa promotes sodium reabsorption and potassium and hydrogen ion secretion in the distal nephron.

Primary aldosteronism (Conn syndrome): Hypertension, hypokalemia, and metabolic alkalosis with high aldosterone and suppressed renin . The screening test is the aldosterone-to-renin ratio (ARR) .

Secondary aldosteronism (renal artery stenosis, heart failure, cirrhosis): Renin and aldosterone are both high.

Parathyroid Hormone and Calcium

  • Condition Total / Ionized Calcium PTH Phosphate
  • Primary hyperparathyroidism (usually adenoma) High High or inappropriately normal Low
  • Secondary hyperparathyroidism (chronic kidney disease, vitamin D deficiency) Low or normal High High in CKD
  • Hypercalcemia of malignancy (PTH-related peptide) High Suppressed Low or normal
  • Hypoparathyroidism (often after thyroid surgery) Low Low High
  • Antidiuretic Hormone (ADH, Vasopressin)

SIADH: Hyponatremia with low serum osmolality, inappropriately concentrated urine, and urine sodium usually above 30 mmol/L in a euvolemic patient. Causes include small cell lung carcinoma, CNS disease, and drugs.

Diabetes insipidus: Polyuria with dilute urine and high-normal or high serum osmolality. A water deprivation test followed by desmopressin separates central DI (urine concentrates after desmopressin) from nephrogenic DI (no response).

5. Anterior Pituitary: Growth Hormone and Prolactin

Growth hormone (GH) is secreted in pulses, so a random GH level is not useful. Insulin-like growth factor 1 (IGF-1) reflects average GH secretion and is the screening test for acromegaly (adults) and gigantism (before epiphyseal closure). Failure of GH to fall below about 1 µg/L after a 75-g oral glucose load confirms excess; laboratories using ultrasensitive assays apply lower cutoffs. GH deficiency is confirmed with stimulation tests such as the insulin tolerance, arginine, or glucagon test.

Prolactin is the only anterior pituitary hormone under predominantly inhibitory (dopamine) control. Pregnancy, breastfeeding, stress, dopamine antagonists (antipsychotics, metoclopramide), and primary hypothyroidism (TRH stimulates prolactin) raise it. A prolactinoma causes galactorrhea, amenorrhea, and infertility in women and hypogonadism in men.

  • 6. Reproductive Hormones and Human Chorionic Gonadotropin (hCG)
  • hCG

A glycoprotein made by the syncytiotrophoblast . Its alpha subunit is identical to that of LH, FSH, and TSH, so assays target the beta subunit for specificity.

Serum hCG becomes detectable within about 8 to 11 days after conception. In an early viable intrauterine pregnancy, it classically doubles about every 48 to 72 hours, peaks at about 8 to 11 weeks of gestation, and then falls to a lower plateau.

A slow rise or plateau suggests an ectopic or failing pregnancy . Very high levels suggest hydatidiform mole , choriocarcinoma , or multiple gestation. hCG is also a tumor marker for testicular germ cell tumors .

For qualitative urine tests, a first-morning specimen is preferred because it is the most concentrated.

Ovarian, Testicular, and Gonadotropin Tests

The LH surge triggers ovulation about 24 to 36 hours later. A mid-luteal (about day 21 of a 28-day cycle) progesterone level confirms that ovulation occurred.

Menopause and primary ovarian failure show high FSH and LH with low estradiol. Hypogonadotropic hypogonadism shows low gonadotropins with low sex steroids.

Testosterone has a diurnal rhythm, so draw it in the morning. Most circulating testosterone is bound to sex hormone-binding globulin (SHBG) and albumin.

7. Endocrine Test Selection Summary

  • Suspected Disorder First-Line Test Confirmatory or Follow-Up Test
  • Primary hypothyroidism / hyperthyroidism TSH Free T4 (and free T3 for hyperthyroidism); thyroid antibodies

Cushing syndrome 24-hour urine free cortisol, late-night salivary cortisol, or 1-mg overnight DST Plasma ACTH to separate ACTH-dependent from ACTH-independent disease

  • Addison disease Morning cortisol with ACTH Cosyntropin (ACTH) stimulation test
  • Pheochromocytoma Plasma free or urine fractionated metanephrines Imaging after biochemical confirmation
  • Primary aldosteronism Aldosterone-to-renin ratio Saline or captopril suppression testing
  • Acromegaly IGF-1 GH suppression after 75-g oral glucose

Prolactinoma Serum prolactin Dilution (hook effect) and PEG precipitation (macroprolactin) when results do not fit

Pregnancy / trophoblastic disease Beta-hCG Serial quantitative hCG